NCT02946788: A trial that was reported late by BioPharmX, Inc.
This trial has reported, although it was 1128 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02946788 |
|---|---|
| Title | An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 13, 2017 |
| Completion date | June 1, 2018 |
| Required reporting date | June 1, 2019, midnight |
| Actual reporting date | July 3, 2022 |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | 1128 |